William David

2.6k citations

18 papers · 962 indexed · 1 hit paper · h-index 11

Impact in

Genetics top 2%
- Neurogenetic and Muscular Disorders Research
Neurology top 2%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism

Papers in ⓘ

Neurology 8
- Amyotrophic Lateral Sclerosis Research 6
Genetics 5
- Neurogenetic and Muscular Disorders Research 4

Co-authors: Merit Cudkowicz (4 shared papers)David Schoenfeld (3 shared papers)Eric A. Macklin (4 shared papers)Stanley H. Appel (2 shared papers)Ericka Simpson (2 shared papers)C. Frank Bennett (2 shared papers)Lyle W. Ostrow (1 shared paper)Alan Pestronk (1 shared paper)
Journals: Neurology (8 papers)Muscle & Nerve (2 papers)Alzheimer s & Dementia (1 paper)Alzheimer s Research & Therapy (1 paper)Neuropharmacology (1 paper)
Partner nations: United States Switzerland Sweden

In The Last Decade

William David

17 papers receiving 938 citations

Hit Papers

align trajectories log scale

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study 2013 · 492 citations

Peers

Countries citing papers authored by William David

Since Specialization

Citations

This map shows the geographic impact of William David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William David more than expected).

Fields of papers citing papers by William David

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William David. The network helps show where William David may publish in the future.

Co-authors

The 25 scholars most cited alongside William David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William David Line = papers co-authored together William David links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study The Lancet Neurology ·Timothy M. Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H. Appel, Patricia L. Andres, Katy Mahoney, Peggy Allred, K. Alexander, Lyle W. Ostrow, David Schoenfeld, Eric A. Macklin, Daniel A. Norris, Georgios Manousakis, Matthew J. Crisp, Richard Smith, C. Frank Bennett, Kathie M. Bishop, Merit Cudkowicz Hit paper breakdown →	2013	492
2	Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS Neurology ·Michael Benatar, Joanne Wuu, Peter M. Andersen, Nazem Atassi, William David, Merit Cudkowicz, David Schoenfeld	2018	101
3	The ALSSQOL Neurology ·Zachary Simmons, S. H. Felgoise, Barbara A. Bremer, Susan Walsh, David J. Hufford, Mark B. Bromberg, William David, Dallas Forshew, Terry Heiman‐Patterson, E. C. Lai, Leo McCluskey	2006	96
4	Randomized trial of l -serine in patients with hereditary sensory and autonomic neuropathy type 1 Neurology ·Vera Fridman, Saranya Suriyanarayanan, Péter Novák, William David, Eric A. Macklin, Diane McKenna‐Yasek, Kailey Walsh, Razina Aziz‐Bose, Anne Louise Oaklander, Robert S. Brown, Thorsten Hornemann, Florian Eichler	2019	76
5	High-frequency chest wall oscillation in ALS Neurology ·Dale J. Lange, Noah Lechtzin, Cynthia Davey, William David, Terry Heiman‐Patterson, Deborah Gelinas, Brian Becker, Hiroshi Mitsumoto, (unknown)	2006	54
6	Life Springs Scientific American ·D Tara, J.P. Martin, William David	2017	28
7	A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil Alzheimer s Research & Therapy ·Terence Fullerton, Brendon Binneman, William David, Marielle Delnomdedieu, James W. Kupiec, Peter Lockwood, Jessica Mancuso, Jeffrey Miceli, J. Simon Bell	2018	27
8	In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects Neuropharmacology ·Marielle Delnomdedieu, Anton Forsberg, Adam Ogden, Patrik Fazio, Ching‐Ray Yu, Per Stenkrona, Sridhar Duvvuri, William David, Nabil Al‐Tawil, Ottavio V. Vitolo, Nahid Amini, Sangram Nag, Christer Halldin, Andrea Varrone	2017	22
9	Construction and validation of the chronic acquired polyneuropathy patient‐reported index (CAP‐PRI): A disease‐specific, health‐related quality‐of‐life instrument Muscle & Nerve ·Kelly Gwathmey, Mark R. Conaway, Reza Sadjadi, Amruta Joshi, Carolina Barnett, Vera Bril, Eduardo Ng, William David, Karissa Gable, Jeffrey T. Guptill, Lisa D. Hobson‐Webb, Jennifer Dineen, Michael K. Hehir, Thomas H. Brannagan, Esther Byun, Margaret Adler, Ted M. Burns	2015	17
10	Clinical myopathy in patients with nephropathic cystinosis Muscle & Nerve ·Reza Sadjadi, Stacey Sullivan, Natalie Grant, Susan E. Thomas, Maya Doyle, Colleen Hammond, Rachel Duong, Camille Corre, William David, Florian Eichler	2019	15
11	Seeking a measure of clinically meaningful change in ALS Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Martin McElhiney, Judith G. Rabkin, Raymond R. Goetz, Jonathan Katz, Robert G. Miller, Dallas Forshew, William David, Merit Cudkowicz, Jonathan D. Glass, Stanley H. Appel, Ericka Simpson, Hiroshi Mitsumoto	2014	13
12	Quality improvement in neurology Neurology ·Pushpa Narayanaswami, Richard Dubinsky, David Wang, Gina Gjorvad, William David, Jonathan D. Finder, Benn Smith, Jianguo Cheng, Frederic Shapiro, Michelle Mellion, Christopher F. Spurney, Jodi Wolff, John D. England	2015	9
13	Results of a Phase 1, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of ISIS 333611 Administered Intrathecally to Patients with Familial ALS Due to SOD1 Gene Mutations (S25.001) Neurology ·Timothy M. Miller, Richard Smith, A. Pestronk, William David, Jeffrey D. Rothstein, Elizabeth Simpson, Patricia L. Andres, Katy Mahoney, Peggy Allred, K. Alexander, Kathie M. Bishop, David Schoenfeld, Eric A. Macklin, Daniel A. Norris, C. Frank Bennett, Merit Cudkowicz	2012	4
14	Neuromuscular Disorders Seminars in Neurology ·David A. Chad, William David	2015	3
15	Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes (S21.003) Neurology ·Divyanshu Dubey, William David, Kerry L. Reynolds, Donald F. Chute, Nathan F. Clement, Justine V. Cohen, Donald P. Lawrence, Meghan J. Mooradian, Ryan J. Sullivan, Amanda C. Guidon	2019	2
16	A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DELAYED-START TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF L-SERINE IN SUBJECTS WITH HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1 (HSAN1) (S45.001) Neurology ·Vera Fridman, Péter Novák, William David, Eric A. Macklin, Diane McKenna‐Yasek, Kailey Walsh, Anne Louise Oaklander, Robert H. Brown, Thorsten Hornemann, Florian Eichler	2017	2
17	P1‐047: A Phase 2 Clinical Trial of PF‐05212377 (SAM‐760) in Subjects with Mild to Moderate Alzheimer's Disease with Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil Alzheimer s & Dementia ·Terence Fullerton, Brendon Binneman, William David, Marielle Delnomdedieu, James W. Kupiec, Peter Lockwood, Jessica Mancuso, Jeffrey Miceli, J. Simon Bell	2016	1
18	Mechanical stimulation of intervertebral disc cells by cyclic hydrostatic pressure Merryman, William David	2002	0

About William David

William David is a scholar working on Neurology, Genetics, Biochemistry, Pharmacology and Pathology and Forensic Medicine, having authored 18 papers that have together received 962 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (4 papers), Hereditary Neurological Disorders (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Treatment of Major Depression (2 papers), Metabolism and Genetic Disorders (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Genetics (367 citations), Neurology (507 citations), Cellular and Molecular Neuroscience (197 citations), Neurology (81 citations) and Molecular Biology (436 citations). William David has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include Merit Cudkowicz, David Schoenfeld, Eric A. Macklin, Stanley H. Appel, Ericka Simpson, C. Frank Bennett, Lyle W. Ostrow, Alan Pestronk, Kathie M. Bishop and Timothy M. Miller. Their work appears in journals such as Neurology, Muscle & Nerve, Alzheimer s & Dementia, Alzheimer s Research & Therapy and Neuropharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact